Open-Label Extension Study of the Phase 3 VRX-RET-E22-302 Double-Blind Trial. 115097
Clinical trial NCT00310388 · TERMINATED
Trial details
- NCT number
- NCT00310388
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-07-05
- Primary completion
- 2017-04-18
- Enrollment
- 376
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.